TRX103

Overview

TRX103 is an off-the-shelf allogeneic T-cell therapy that may help to prevent graft versus host disease in patients who receive bone marrow transplants. 

SparkCures ID 773
Generic Name TRX103
Treatment Classifications
  • T Cell (Allogeneic)

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.